Expressing disapproval of the decision by the Supreme Court in Sorrell v. IMS Health Inc.

Summary

Disapproves of the majority opinion in Sorrell v. IMS Health Inc. , because it puts prescribers at risk of having their prescriber-identifying information sold without their knowledge or consent. Expresses the belief of the House of Representatives that: (1) the Supreme Court incorrectly applied a heightened First Amendment standard of review to an instance of commercial regulation; (2) the negative impact on a pharmaceutical manufacturer's ability to market its products is outweighed by the interests of patient safety, doctor privacy, and health care costs; and (3) the states have the right to regulate the pharmaceutical industry based on what is best for the health and safety of their residents.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 8 July 2011

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 8 July 2011

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 8 July 2011

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.